Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.530
-0.010 (-0.39%)
At close: Dec 5, 2025, 4:00 PM EST
2.500
-0.030 (-1.19%)
After-hours: Dec 5, 2025, 7:55 PM EST
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $5.8 million as of December 5, 2025. Its market cap has decreased by -3.39% in one year.
Market Cap
5.80M
Enterprise Value
1.67M
1-Year Change
-3.39%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $5.80M, a decrease of -87.85%. That is a compound annual growth rate of -20.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 5.80M | -6.45% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |